Corrigendum to ‘Management of Chronic Venous Disease: Clinical Practice Guidelines’ [European Journal of Vascular &amp; Endovascular Surgery 49/6 (2015) 678/737]

Wittens, Cees H. A.; Davies, AH; Bækgaard, N; Broholm, Rikke; Cavezzi, Attilio; Chastanet, S.; Wolf, Maarten de; Eggen, C.A.M.; Giannoukas, A.; Gohel, M.S.; Kakkos, S.; Lawson, James A.; Noppeney, T.; Onida, Sarah; Pittaluga, Paul; Thomis, Sarah; Toonder, Irwin M.; Vuylsteke, Marc; Kolh, Philippe; Borst, G.J. de; Chakfé, Nabil; Debus, Sebastian; Hinchliffe, RJ; Končar, Igor; Lindholt, Jes Sanddal; Céniga, Melina Vega de; Vermassen, Frank; Verzini, Fabio; Maeseneer, M. De; Blomgren, Lena; Hartung, Olivier; Kalodiki, Evi; Korten, Eunice; Lugli, Marzia; Naylor, Ross; Nicolini, Philippe; Rosales, Antonio

doi:10.1016/j.ejvs.2019.11.027

Cited by 16 publications

(23 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…74 However, various options are available to treat larger diseased veins. The American Society for Vascular Surgery and American Venous Forum, 75 National Institute for Health and Care Excellence, 76 and European Society for Vascular Surgery 77 agree that while endovenous thermal ablation is recommended as first choice, ultrasound-guided foam sclerotherapy is preferred to surgery. Sclerotherapy is the most widely practiced form of treatment in most countries.…”

Section: Resultsmentioning

confidence: 99%

A history of injection treatments – II sclerotherapy

Myers

2018

Phlebology

View full text Add to dashboard Cite

Introduction Sclerotherapy in all its current forms is based on experience going back to the 1850s. Methods To trace the evolution of sclerotherapy over the past 250 years, using the internet for past documentation and the literature. Conclusion Sclerotherapy principles were established long ago, although current modifications have been made possible by the introduction of detergent sclerosants and ultrasound guidance.

show abstract

Section: Resultsmentioning

confidence: 99%

A history of injection treatments – II sclerotherapy

Myers

2018

Phlebology

View full text Add to dashboard Cite

show abstract

“…Because our study endpoint required a suitable method for assessing the underlying characteristics of the disease condition and investigation of the potential risk factors, we conducted a single-center registry-based cohort study. 17 The eligible participants were all patients who underwent endovenous CA procedures. The surgical indication for the procedure was superficial truncal vein reflux (>1 second in duplex ultrasound [DUS]) with persistent chronic venous leg symptoms without improvement from conservative medico-social therapy.…”

Section: Methodsmentioning

confidence: 99%

Incidence and Clinical Impact of Endovenous Glue-Induced Hypersensitivity Among Patients Who Underwent Endovenous Cyanoacrylate Ablation Procedures: A Registry-Based Cohort Study

Yie

Shin

Jung

et al. 2023

View full text Add to dashboard Cite

BACKGROUND The characteristics of endovenous glue-induced hypersensitivity (EGIH) remain unclear. OBJECTIVE To assess the clinical impacts on patients with EGIH after endovenous cyanoacrylate-glue ablation (CA). MATERIALS AND METHODS A prospectively designed endovenous CA-specific registry was created, and a total of 335 limbs from 173 patients who underwent endovenous CA were enrolled for a cohort study. RESULTS Symptomatic EGIH was observed in 55 (31.8%) patients. Beyond the target vein area, systemic side effects were noted in 5.8% of the treated patients after CA. The median onset time was 13 postoperative days (range: 1-35 days). The median duration was 7 days, but about 10.9% of the affected patients experienced symptoms lasting longer than 4 weeks. In the EGIH and non-EGIH groups, significant improvements in venous clinical severity score and Chronic Venous Insufficiency Quality of Life Questionnaire-14 scores were observed 3 months postoperatively. The development of EGIH did not affect the postoperative patient-reported satisfaction scores (p 5 .524). CONCLUSION EGIH is observed in a substantial proportion of patients. The side effects do not affect the clinical outcomes and patient-reported outcome measures. Further studies are required on the detailed pathogenesis and definition of EGIH.

show abstract

“…Catheter-based endovenous thermal ablation (EVTA) is now the first choice of treatment for varicose veins caused by truncal vein reflux in America, 1 the UK 2 and Europe. 3 The two most widely used forms of EVTA are radio-frequency ablation 4 (RFA) and endovenous laser ablation 5…”

Section: Introductionmentioning

confidence: 99%

Vein wall thickness (VWT) and catheter size are more important than vein diameter in optimising endovenous thermal ablation (EVTA) – results of a mathematical model of how VWT changes when veins constrict under tumescence.

Fernandez-Hart¹,

Santos²,

Whiteley³

2023

Preprint

View full text Add to dashboard Cite

Background: Catheter-based endovenous thermal ablation (EVTA) under tumescent anaesthesia is the standard treatment for truncal venous reflux. Doctors often use vein diameter alone to select treatment settings and protocols. Adequate venous ablation requires thermal energy to penetrate the vein wall deeply and probably transmurally. Hence the thicker the vein wall when constricted during treatment, the deeper the required thermal penetration. We constructed a mathematical model to predict vein wall thickness (VWT) during EVTA of veins of different diameters, initial wall thicknesses and device diameters. Methods:A mathematical model was constructed under the simplifying assumptions that the vein is a perfect circle, that the wall has a constant volume and that it constricts uniformly without folding. A set of representative vein diameters and thicknesses, and common device diameters were applied to the model to study the variables. Results:Numerical analysis predicted that vein walls would thicken when constricted compared to their initial state. Veins that initially had thicker walls and larger diameters, had thicker walls when constricted than thin walled or small diameter veins, using the same size EVTA devices. For each vein, as the diameter of the device decreased, the constricted VWT increased. Sensitivity analysis of the variables affecting the constricted VWT revealed that the initial VWT was most important, followed by device diameter and finally initial diameter of the vein. Conclusion:Our model shows that for a range of vein sizes and wall thicknesses, the constricted VWT increases markedly with decreasing device size. Although doctors often use vein diameter to select treatment parameters, this model suggests that initial VWT followed by the size of EVTA device are more important variables. Furthermore, the current trend to make EVTA devices thinner may be disadvantageous, as this increases the constricted VWT at treatment, making adequate thermal penetration harder to achieve.

show abstract

Corrigendum to ‘Management of Chronic Venous Disease: Clinical Practice Guidelines’ [European Journal of Vascular & Endovascular Surgery 49/6 (2015) 678/737]

Cited by 16 publications

References 0 publications

A history of injection treatments – II sclerotherapy

A history of injection treatments – II sclerotherapy

Incidence and Clinical Impact of Endovenous Glue-Induced Hypersensitivity Among Patients Who Underwent Endovenous Cyanoacrylate Ablation Procedures: A Registry-Based Cohort Study

Vein wall thickness (VWT) and catheter size are more important than vein diameter in optimising endovenous thermal ablation (EVTA) – results of a mathematical model of how VWT changes when veins constrict under tumescence.

Contact Info

Product

Resources

About